Siglinde Wolf

839 total citations
11 papers, 688 citations indexed

About

Siglinde Wolf is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Siglinde Wolf has authored 11 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Siglinde Wolf's work include Cancer-related Molecular Pathways (7 papers), Chemical Synthesis and Analysis (6 papers) and Click Chemistry and Applications (5 papers). Siglinde Wolf is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Chemical Synthesis and Analysis (6 papers) and Click Chemistry and Applications (5 papers). Siglinde Wolf collaborates with scholars based in United States, Germany and Netherlands. Siglinde Wolf's co-authors include Tad A. Holak, Grzegorz M. Popowicz, Alexander Dömlingꝉ, Anna Czarna, Wei Wang, Yijun Huang, Michał Biśta, Kan Wang, Carlos J. Camacho and Barbara Beck and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Structure.

In The Last Decade

Siglinde Wolf

11 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siglinde Wolf United States 11 486 330 310 93 50 11 688
Keiichi Masuya Switzerland 15 463 1.0× 355 1.1× 341 1.1× 67 0.7× 93 1.9× 41 869
Cynthia M. Shafer United States 17 542 1.1× 475 1.4× 154 0.5× 137 1.5× 33 0.7× 30 880
Henriëtte M. G. Willems United Kingdom 13 317 0.7× 200 0.6× 157 0.5× 91 1.0× 42 0.8× 24 512
Kevin Blades United Kingdom 17 576 1.2× 555 1.7× 217 0.7× 42 0.5× 42 0.8× 28 1.0k
Marc Labroli United States 11 382 0.8× 548 1.7× 161 0.5× 37 0.4× 51 1.0× 19 943
Maria Gabriella Brasca Italy 17 345 0.7× 276 0.8× 186 0.6× 82 0.9× 91 1.8× 28 663
Jennifer Lattanze United States 10 267 0.5× 188 0.6× 176 0.6× 48 0.5× 49 1.0× 11 411
Bryan Lanning United States 4 745 1.5× 480 1.5× 216 0.7× 82 0.9× 73 1.5× 8 982
Kareem Khoury United States 16 361 0.7× 409 1.2× 123 0.4× 80 0.9× 25 0.5× 22 644
Corey L. Strickland United States 10 434 0.9× 193 0.6× 156 0.5× 68 0.7× 76 1.5× 22 609

Countries citing papers authored by Siglinde Wolf

Since Specialization
Citations

This map shows the geographic impact of Siglinde Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siglinde Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siglinde Wolf more than expected).

Fields of papers citing papers by Siglinde Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siglinde Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siglinde Wolf. The network helps show where Siglinde Wolf may publish in the future.

Co-authorship network of co-authors of Siglinde Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Siglinde Wolf. A scholar is included among the top collaborators of Siglinde Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siglinde Wolf. Siglinde Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Huang, Yijun, et al.. (2014). Fragment-Based Library Generation for the Discovery of a Peptidomimetic p53-Mdm4 Inhibitor. ACS Combinatorial Science. 16(8). 393–396. 12 indexed citations
2.
Huang, Yijun, Siglinde Wolf, Barbara Beck, et al.. (2014). Discovery of Highly Potent p53-MDM2 Antagonists and Structural Basis for Anti-Acute Myeloid Leukemia Activities. ACS Chemical Biology. 9(3). 802–811. 34 indexed citations
3.
Biśta, Michał, Siglinde Wolf, Kareem Khoury, et al.. (2013). Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction. Structure. 21(12). 2143–2151. 47 indexed citations
4.
Koes, David Ryan, Kareem Khoury, Yijun Huang, et al.. (2012). Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists. PLoS ONE. 7(3). e32839–e32839. 79 indexed citations
5.
Wang, Wei, et al.. (2012). Benzimidazole-2-one: A novel anchoring principle for antagonizing p53-Mdm2. Bioorganic & Medicinal Chemistry. 21(14). 3982–3995. 17 indexed citations
6.
Huang, Yijun, Siglinde Wolf, David Ryan Koes, et al.. (2011). Exhaustive Fluorine Scanning toward Potent p53–Mdm2 Antagonists. ChemMedChem. 7(1). 49–52. 40 indexed citations
7.
Huang, Yijun, Siglinde Wolf, Michał Biśta, et al.. (2010). 1,4‐Thienodiazepine‐2,5‐diones via MCR (I): Synthesis, Virtual Space and p53‐Mdm2 Activity. Chemical Biology & Drug Design. 76(2). 116–129. 50 indexed citations
8.
Popowicz, Grzegorz M., Anna Czarna, Siglinde Wolf, et al.. (2010). Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery. Cell Cycle. 9(6). 1104–1111. 187 indexed citations
9.
Czarna, Anna, Barbara Beck, Stuti Srivastava, et al.. (2010). Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists. Angewandte Chemie International Edition. 49(31). 5352–5356. 113 indexed citations
10.
Czarna, Anna, Barbara Beck, Stuti Srivastava, et al.. (2010). Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists. Angewandte Chemie. 122(31). 5480–5484. 21 indexed citations
11.
Czarna, Anna, et al.. (2009). High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx. Cell Cycle. 8(8). 1176–1184. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026